CP and bacterial infectious disease with sepsis: Additionally, the presence of CP similarly increased tolerance of a clinical MRSA bacteremia isolate and the MRSA laboratory strain JE2 (Table S1) to ceftobiprole, a β-lactam approved for the treatment of MRSA bacteremia (Fig. S1E).